Olmesartan Medoxomil Amlodipine Besylate Hydrochlorothiazide + Aliskiren Interaction
Contraindicatedinteraction on record
Description
Contraindicated in patients with diabetes. Avoid in patients with renal impairment (GFR <60 ml/min). Dual RAS blockade increases risks of hypotension, hyperkalemia, and acute renal failure.
Mechanism
Dual inhibition of renin-angiotensin system
Source: NLP:olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide